ConductScience.org, home

Gene · 10398

Papers1,490

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
TrimNN: characterizing cellular community motifs for studying multicellular topological organization in complex tissues.Nat Commun202540830137PubTator, text miningPubMed
Elucidating the role of LGALS3BP in coronary atherosclerosis: integrating bioinformatics and machine learning for advanced insights.J Cardiothorac Surg202540814096PubTator, text miningPubMed
Prognostic and therapeutic implications related to glycosylation profiles of cancer-associated fibroblasts in colorectal cancer: insights from single-cell and bulk transcriptomics.Funct Integr Genomics202540813526PubTator, text miningPubMed
Deciphering genetic overlaps between pulmonary tuberculosis and GERD for drug target discovery: A structural bioinformatics perspective.Microb Pathog202540769224PubTator, text miningPubMed
RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications.MedComm (2020)202540761481PubTator, text miningPubMed
Endo180 and basement membrane stiffness induce OXPHOS and neoplastic transformation in aging prostate epithelia.NPJ Aging202540753084PubTator, text miningPubMed
An integrated approach for key gene selection and cancer phenotype classification: Improving diagnosis and prediction.Comput Biol Med202540618695PubTator, text miningPubMed
Differentially expressed genes in the placentas with pre-eclampsia and fetal growth restriction using RNA sequencing and verification.J Perinat Med202540285515PubTator, text miningPubMed
Overexpression of LMOD1 induces oxidative stress and enhances cell apoptosis of melanoma through the RIG-I like receptor pathway.Biochim Biophys Acta Mol Basis Dis202540068386PubTator, text miningPubMed
Quantitative Proteome and Phosphoproteome Profiling across Three Cell Lines Revealed Potential Proteins Relevant to Nasopharyngeal Carcinoma Metastasis.J Proteome Res202539970938PubTator, text miningPubMed
Multivariate Cox regression analysis of prognostic genes and therapeutic mechanisms of gastric cancer.Discov Oncol202539921793PubTator, text miningPubMed
Prolonged high Myl9 levels are associated with the pathogenesis and respiratory symptom of post-acute COVID-19 syndrome: A 6-month follow-up study.Clinics (Sao Paulo)202539879907PubTator, text miningPubMed
Exploring markers in nursing care of prostate cancer.Medicine (Baltimore)202539854742PubTator, text miningPubMed
Myosin Light Chain 9 Mediates Graft Fibrosis After Pediatric Liver Transplantation Through TLR4/MYD88/NF-κB Signaling.Cell Mol Gastroenterol Hepatol202539778656PubTator, text miningPubMed
Genome-wide methylation and transcriptome differential analysis of skeletal muscle in broilers with valgus-varus deformity.Br Poult Sci202539504239PubTator, text miningPubMed
MYL9 binding with MYO19 suppresses epithelial-mesenchymal transition in non-small-cell lung cancer.Physiol Genomics202539437553PubTator, text miningPubMed
CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.
Mol Oncol202539322998PubTator, text miningPubMed
Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma.Front Microbiol202439735192PubTator, text miningPubMed
Linking planar polarity signalling to actomyosin contractility during vertebrate neurulation.Open Biol202439561813PubTator, text miningPubMed
Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.Cell Oncol (Dordr)202439419942PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10398/papers?page=3